Table 3.
Univariate and multivariate analysis of overall survival
| Variable | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
|
Age (1 year increasing) (>60 vs ≤60) |
1.155 8.778 |
1.049‐1.273 1.078‐71.452 |
.001 .014 |
1.164 | 1.019‐1.331 | .025 |
| Gender (Male vs female) | 2.956 | 0.594‐14.709 | .165 | |||
| Symptom (Present vs absent) | 34.188 | 0.044‐26818.762 | .083 | |||
| Symptom B (Present vs absent) | 0.351 | 0.042‐2.897 | .310 | |||
| No. of lesions (1 level increasing) | 3.660 | 1.099‐12.188 | .014 | 5.081 | 0.705‐36.628 | .107 |
| Therapy (Surgery vs biopsy) | 0.273 | 0.033‐2.226 | .194 | 3.681 | 0.089‐151.739 | .492 |
| Chemo‐ or radio‐therapy (Present vs absent) | 0286 | 0.057‐1.427 | .104 | 0.080 | 3.315 | .485 |
| Stage (II, III, IV vs I) | 1.580 | 0.389‐6.423 | .519 | |||